Detalhe da pesquisa
1.
TET1 reprograms the epithelial ovarian cancer epigenome and reveals casein kinase 2α as a therapeutic target.
J Pathol
; 248(3): 363-376, 2019 07.
Artigo
Inglês
| MEDLINE | ID: mdl-30883733
2.
LIM-homeobox transcription factor 1, alpha (LMX1A) inhibits tumourigenesis, epithelial-mesenchymal transition and stem-like properties of epithelial ovarian cancer.
Gynecol Oncol
; 128(3): 475-82, 2013 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-23270808
3.
Pyruvate kinase M2 is a poor prognostic marker of and a therapeutic target in ovarian cancer.
PLoS One
; 12(7): e0182166, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-28753677
4.
Ovarian cancer stem-like cells show induced translineage-differentiation capacity and are suppressed by alkaline phosphatase inhibitor.
Oncotarget
; 4(12): 2366-82, 2013 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-24280306